Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to comment on "A quantitative metric of immune responses with applications in vaccines, cancer immunity, autoimmunity, and anti-drug antibody monitoring".

Journal of pharmaceutical sciences·2026
Same author

A quantitative metric of immune responses with applications in vaccines, cancer immunity, autoimmunity, and anti-drug antibody monitoring.

Journal of pharmaceutical sciences·2026
Same author

Cytokine expression mediated immunogenic response of therapeutic IgG aggregates obtained by forced degradative stress factors and the role of a deep neural network in its prediction.

Biochemical and biophysical research communications·2026
Same author

Correction to: Brain dystrophinopathies and cognitive impairment: Pathogenesis, diagnosis, and therapies.

Journal of biosciences·2026
Same author

Brain dystrophinopathies and cognitive impairment: Pathogenesis, diagnosis, and therapies.

Journal of biosciences·2025
Same author

Interpreting immunogenicity in oncology clinical trials.

Cancer treatment reviews·2025
Same journal

A simple, sensitive microsample LC-MS assay for quercetin and isorhamnetin in mouse and human plasma: application to EMIQ treatment in myotonic dystrophy type 1.

Bioanalysis·2026
Same journal

ADA assays for high-dose biologics: redefining drug tolerance through clinical insights.

Bioanalysis·2026
Same journal

Comparison of SERS spectral data sets of blood serum samples of hypopharyngeal cancer using silver and gold nanoparticles as substrates.

Bioanalysis·2026
Same journal

The Gyrolab platform for immunogenicity assessment and biotherapeutic and biomarker analysis: technical advances and bioanalytical applications.

Bioanalysis·2026
Same journal

Simultaneous quantification of D-penicillamine, D-penicillamine disulfide, and L-cysteine-D-penicillamine disulfide in human plasma: optimization of sample preparation and mass spectrometry procedures to support bioequivalence studies.

Bioanalysis·2026
Same journal

Development and preliminary clinical application of a time-resolved fluoroimmunoassay for anti-rituximab antibodies in membranous nephropathy.

Bioanalysis·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Assessing specificity for immunogenicity assays.

Steven J Swanson1, Narendra Chirmule

  • 1Clinical Immunology Department, Amgen Inc., One Amgen Center Drive, 30E-3-B, Thousand Oaks, CA 91320, USA. swanson@amgen.com

Bioanalysis
|November 19, 2010
PubMed
Summary
This summary is machine-generated.

Developing specific bioanalytical assays is crucial for measuring immunogenicity of biological drugs. These methods ensure accurate detection of antidrug antibodies, confirming specificity and aiding drug development and safety assessments.

More Related Videos

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
06:15

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay

Published on: September 7, 2018

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

Related Experiment Videos

Last Updated: Jun 6, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
06:15

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay

Published on: September 7, 2018

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

Area of Science:

  • Pharmacology and Toxicology
  • Immunology
  • Bioanalytical Chemistry

Background:

  • Accurate measurement of immunogenicity is vital for biological therapeutics.
  • Sensitive assays detect low-affinity antibodies but risk false positives.
  • Specificity assays are essential to confirm antidrug antibodies (ADAs).

Purpose of the Study:

  • To discuss methodologies for determining specificity in bioanalytical assays for ADAs.
  • To provide guidelines for developing and reviewing ADA assays.
  • To ensure assays specifically detect antibodies interfering with drug action or safety.

Main Methods:

  • Review of methodologies for ADA specificity determination.
  • Discussion of assay capabilities in detecting antibody binding and neutralization.
  • Focus on strategies to mitigate false-positive results from sensitive screening assays.

Main Results:

  • Established methodologies for confirming ADA specificity.
  • Guidelines for assay development and regulatory review.
  • Improved confidence in detecting clinically relevant ADAs.

Conclusions:

  • Specific bioanalytical assays are critical for reliable ADA measurement.
  • Methodologies discussed enhance the accuracy of immunogenicity testing.
  • These approaches support safe and effective biological drug development.